Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director
-
Polar Power Receives Nasdaq Confirmation of Stockholders’ Equity Compliance; Advances Next Phase of Restructuring
-
Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium
-
Riot Platforms Reports Third Quarter 2026 Financial Results and Strategic Highlights
-
Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting
-
Medline Reports Third Quarter and Nine Months 2026 Results
-
Eagle Nuclear Energy Signs Binding LOI to Acquire Noble Plains Uranium
-
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
-
Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
-
Bread Financial to Participate in the KBW Fintech Ecosystem Conference
-
Form 8.3 - Ramsdens Holdings Plc
-
Vishay Intertechnology Reports Third Quarter 2026 Results
-
Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2026
-
uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update
-
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
-
Kane Announces Publication of Real-World Evidence in the International Wound Journal
-
Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
-
Avista Corp. Reports Q3 2026 Financial Results, Confirms 2026 Utility Earnings Guidance
-
Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
-
Purpose Investments Adds an Active Equity Fund to the Purpose Active Suite (TSX: PAEF)
-
Condor Production Surpasses 18,500 boe/d as the 2026 Multi-Well Drilling Program Continues to Outperform
-
BioCryst Reports Third Quarter 2026 Financial Results
-
Biora Therapeutics Receives Approval for First-in-Human Trial of BioJet™ Oral Biologic Delivery Capsule
-
Qarakal Quantum to Deliver Keynote Presentation at World Quantum Cannes Festival
-
Aya Gold & Silver Drill Results Confirm High-Grade Continuity at Boumadine; New Permits Secured
-
Canfor reports results for the third quarter of 2026
-
Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026
-
ARRAY Technologies Reports Financial Results for the Third Quarter 2026
-
Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases
-
Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
-
Phoenix Metals Strengthens Executive Team With Addition of Veteran CFO
-
Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
-
Brink's Delivers Strong Third-Quarter Results
-
Tonix Pharmaceuticals to Present at Guggenheim’s 3rd Annual Healthcare Innovation Conference
-
Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)
-
Rate and Compass International Holdings Make Landmark Move, Combining Their Two Joint Ventures, Creating Top 10 U.S. Retail Lending Leader: OriginPoint
-
Sprott Announces Third Quarter 2026 Results
-
Repligen Corporation to Present at Jefferies Global Healthcare Conference
-
Flutter Entertainment PLC: Q3 2026 Earnings Release
-
ARRAY Technologies and Shoals Technologies Group Announce Transformative Merger, Creating an Integrated Energy Infrastructure Platform
-
Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets
-
Medicenna Completes Phase 1/2 ABILITY-1 Enrollment and Announces Webinar to Discuss Updated MDNA11 Results with Key Opinion Leaders
-
BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting
-
HP Inc. Appoints Emma Walmsley as Chief Executive Officer
-
Agora, Inc. to Report Third Quarter 2026 Financial Results on November 16, 2026
-
RYTHM, Inc. Reports Third Quarter 2026 Results
-
Rapport Therapeutics Reports Third Quarter 2026 Financials and Provides Business Update
-
Royalty Pharma reports third quarter 2026 results
-
Brunswick Exploration Reports 1.73% Li2O Over 302 Meters Including 142 Meters at 1.97% Li2O at the Anatacau Main Project
